[Peculiarities of neuro-psychological and autonomic disorders in patients with remote consequences of closed craniocerebral injury].
62 patients who had undergone mild craniocerebral injury have taken part in the study. All patients had a complex examination before the treatment. This examination included together with laboratory and instrumental methods the following scales: vegetovascular Vein's scale for a patient and physician, feeling scale (psychological scale). All patients received the following treatment: analgetics, vasoactive agents, tranquilizers, vitamins of the group B, magnesium sulfate, biostimulants, amino acids, physiotherapy, acupuncture, Patients of the first group received additionally noofen and patients of the second group received aminalon. The duration of the treatment was about two months. Positive dynamics of the course of the disease was noted in patients with late closed craniocerebral injury effect after a complex treatment including nootropic agents was done. However noofen was more effective in patients with closed craniocerebral injury late effect who had asthenic syndrome and vegetative disorders.
Glebova
O S
OS
D000328:Adult; D001247:Asthenia / Q000209:etiology / Q000517:prevention & control / Q000523:psychology; D001342:Autonomic Nervous System Diseases / Q000209:etiology / Q000517:prevention & control / Q000523:psychology; D004359:Drug Therapy, Combination; D005260:Female; D016489:Head Injuries, Closed / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D018697:Nootropic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
D018697:Nootropic Agents